Literature DB >> 3572456

Effects of denervation and immobilisation during development upon [3H]ouabain binding by slow- and fast-twitch muscle of the rat.

K M Ward, W Manning, A C Wareham.   

Abstract

The effect of innervation and of muscle inactivity upon the normal production of Na+-K+-ATPase sites, assayed by [3H]ouabain binding, in muscle surface membranes has been determined for the rat. In both slow-twitch soleus (SOL) and fast-twitch extensor digitorum longus (EDL) muscles a large increase was found to occur in [3H]ouabain binding per unit weight of muscle over the first 3 weeks of life. Interruptions of development, brought about by fixation of muscles at different lengths at 5 days of age, had no significant effect upon [3H]ouabain binding by EDL. In contrast, fixation led to a decrease in binding in SOL. When fixed in a shortened position profound morphological changes occurred, although these were not apparent when SOL was fixed in a stretched position. Denervation of SOL at 5 days of age significantly reduced the age related increase in the density of [3H]ouabain binding, whilst denervation of EDL had little effect. It was concluded that normal development of SOL is dependent upon innervation and possibly the resulting muscle activity, whereas development of EDL was relatively independent of innervation.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3572456     DOI: 10.1016/0022-510x(87)90062-1

Source DB:  PubMed          Journal:  J Neurol Sci        ISSN: 0022-510X            Impact factor:   3.181


  2 in total

1.  Immobilization atrophy and membrane properties in rat skeletal muscle fibres.

Authors:  H Zemková; J Teisinger; R R Almon; R Vejsada; P Hník; F Vyskocil
Journal:  Pflugers Arch       Date:  1990-04       Impact factor: 3.657

2.  Angiotensin 1-7 prevents the excessive force loss resulting from 14- and 28-day denervation in mouse EDL and soleus muscle.

Authors:  Hind Albadrani; T Ammar; Michael Bader; Jean-Marc Renaud
Journal:  J Gen Physiol       Date:  2021-11-05       Impact factor: 4.000

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.